openPR Logo
Press release

Autoimmunity in myocarditis and dilated cardiomyopathy

02-05-2014 06:54 PM CET | Health & Medicine

Press release from: Pabst Science Publishers

Y. Shoenfeld, P.L. Meroni (Eds.) The General Practice Guide to Autoimmune Diseases

Y. Shoenfeld, P.L. Meroni (Eds.) The General Practice Guide to Autoimmune Diseases

Autoimmune Diseases: "Myocarditis is an acquired inflammatory condition involving the myocardial tissue. Although myocarditis is largely associated with viral infections, some cases remain idiopathic, while in others there is convincing evidence of autoimmune pathophysiology. Autoimmunity is influenced by genetic, immune, hormonal and environmental factors. Myocardial injury (due to infection, ischaemia, inflammation, toxins or other cardiotoxic factors) may trigger exposure to autoantigens, subsequently, initiating an autoimmune response, causing myocarditis and dilated cardiomyopathy. Nevertheless, in some cases no specific trigger is found," Dres. Udi Nussinovitch and Yehuda Shoenfeld (Israel) report in their new textbook "The General Practice Guide to Autoimmune Diseases".

Signs and symptoms of myocarditis and dilated cardiomyopathy (DCM) are:

- History of an upper respiratory illness or recent viral infection in some patients (myocarditis)
- A number of myocarditis cases are subclinical
- Asymptomatic cardiomegaly
- Symptomatic left- and right- heart failure
- Physical examination findings consistent with heart failure
- Chest pain on exertion or at rest
- Dyspnoea on exertion or at rest
- Fatigue
- Palpitations and arrhythmias (both ventricular and supra-ventricular)
- Peripheral pitting oedema
- Systemic and pulmonary embolisms
- Syncope
- Elevated serum levels of myocardial enzymes (in myocarditis)
- Electrocardiographic changes
- Sudden death

"Clinically, myocarditis may be asymptomatic or present with chest pain, palpitations, ECG changes, syncope, arrhythmias. Early diagnosis may be extremely challenging since signs and symptoms may be unspecific. Clinically, DCM is most commonly characterized as symptomatic heart failure. Prior to confirmation of a diagnosis of autoimmune myocarditis/DCM, proof of autoimmunity may be required. Evidence of autoimmune myocarditis/DCM may be found in a mononuclear cell infiltrate presenting with an abnormal human leukocyte antigen (HLA), presence of circulating anti-heart autoantibodies (AHA) or autoreactive lymphocytes in patients, and in unaffected family members, and in in-situ evidence of autoreactive lymphocytes and/or autoantibodies in cardiac tissue..."

>> Y. Shoenfeld, P.L. Meroni (Eds.) The General Practice Guide to Autoimmune Diseases. Pabst, 332 pages, ISBN 978-3-89967-770-6

Pabst Science Publishers (Lengerich/Westfalen) veröffentlicht zehn psychologische und neun medizinische Fachzeitschriften; darüber hinaus erscheinen bei Pabst aus den gleichen Fachbereichen mehr als hundert Bücher jährlich - teils wissenschaftliche Spezialtitel, teils allgemeinverständliche Fachliteratur.

Pabst Science Publishers
Eichengrund 28
49525 Lengerich
Tel. 05484-308
Fax 05484-550
E-Mail: pabst.publishers@t-online.de
Internet: www.pabst-publishers.de / www.psychologie-aktuell.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autoimmunity in myocarditis and dilated cardiomyopathy here

News-ID: 281093 • Views: 4008

More Releases from Pabst Science Publishers

Health literacy: How to improve health behaviors
Health literacy is defined as "people´s knowledge, motivation and competences to access, understand, appraise and apply information to make judgements and take decisions in everyday life healthcare concerning disease prevention and health promotion to maintain and improve quality of life during the life course." In a new volume Anne-Kathrin Mayer and colleagues shed light on the concept of health literacy from different disciplines: psychology, educational sciences, health sciences and
Health literacy: how to improve the advantages and to reduce the risks
The new volume "Health literacy across the lifespan" stresses the importance of health literacy for changing multiple health-risk-factors. Anne-Kathrin Mayer and colleagues shed light on a concept from different disciplines: psychology, educational sciences, health sciences and public health, communication sciences, and information sciences. It is undisputed that health is strongly influenced by individual efforts aimed at the promotion of health and the prevention of illness or recovery from diseases. These
Directed deceased donation: beyond the impartial allocation system
"Within a pluralistic account of morality, partial values have a merit of their own and should be assessed in their own terms. These values are extremely relevant in the field of organ transplantation, but are misunderstood at a political level where partiality is put at par with injustice, and where fairness is exclusively taken as impartial justice." Dr. Medard Hilhorst (Erasmus Medical University Rotterdam) argues "that partial values are fundamental
Transplantation: Prisoners are killed for their organs in China
Transplantation: China is the only country in the world systematically using organs from prisoners for transplantation, Professor Huige Li reports. For over 40 years, executed prisoners were used as the main organ source in China. It´s a profitable international business. A number of Chinese Hospitals claimed that they could provide liver transplants in the time range between 3 to 30 days. The report appeared in "Ethical, Legal and Psychosocial Aspects

All 5 Releases


More Releases for Autoimmune

Autoimmune Disease Therapeutics Market Boost due to increase in incidence of aut …
According to a new report published by Allied Market Research, titled,"Autoimmune Disease Therapeutics Market by Drug Class, Indication, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is expected to reach $153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5185?utm_source=openpr&utm_medium=Niranjan Autoimmune disease therapeutics include
Autoimmune Treatment Market North America Leads the Global Autoimmune Treatment …
The global autoimmune treatment market is growing significantly due to increasing incidences of autoimmune diseases, up surging healthcare expenditure, and advancements in the technologies for the development of autoimmune diseases therapeutics. Autoimmune diseases are chronic in nature and do not have permanent treatment. This creates ample growth opportunity for the autoimmune treatment market, to grow at a considerable rate in the coming years. The advanced research and development facilities, and
Autoimmune Disease Diagnostics Market: Rise in Autoimmune Diseases, alongside Gr …
Global Autoimmune Disease Diagnostics Market: Snapshot The global autoimmune disease diagnostics market is expected to witness a modest growth in the coming years on account of the growing incidences of autoimmune diseases among people worldwide. Efficient autoimmune disease diagnostics has become absolutely essential to tackle this issue. Governments across nations are also increasing their spending towards healthcare in light of these growing incidences of autoimmune diseases. This has also resulted in
Autoimmune Disease Diagnostics Market Growth Analysis 2023
Despite its vendor landscape being highly consolidated, intense rivalry prevails among key players in The Global Autoimmune Disease Diagnostics Market. According to Transparency Market Research (TMR), the top four companies held over 50% of the global autoimmune disease diagnostics market in 2014. Among the leading enterprises, F. Hoffmann-La Roche Ltd. held the dominant share of over 17% in the market in the same year. In response to the increasing demand for
Autoimmune Disease Diagnostics Market: Growing Awareness Among People About Auto …
The global autoimmune disease diagnostics market is expected to witness a modest growth in the coming years on account of the growing incidences of autoimmune diseases among people worldwide. Efficient autoimmune disease diagnostics has become absolutely essential to tackle this issue. Governments across nations are also increasing their spending towards healthcare in light of these growing incidences of autoimmune diseases. This has also resulted in the research and development of
Global Autoimmune Treatment Market Research Report 2017
Global Autoimmune Treatment Industry 2017 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2017-2020. The research report on global Autoimmune Treatment market offers an in-depth analysis, presenting insights into the key growth factors, which are estimated to encourage growth of the global market. In addition, the research study throws light on the drivers, barriers, latest opportunities, current trends, and the technological developments